Brief: Basilea Pharmaceutica Announces Divestment Of Its Chinese Research And Development

Basilea Pharmaceutica AG, Allschwil

15/02/2021 06:16

Feb 15 (Reuters) - BASILEA PHARMACEUTICA AG  BSLN.S :
    * ANNOUNCES DIVESTMENT OF ITS CHINESE RESEARCH AND
DEVELOPMENT
SUBSIDIARY TO PHT INTERNATIONAL
    * TOTAL PURCHASE PRICE OF USD 6.3 MILLION.
    * INITIAL PAYMENT IS USD 2.5 MILLION
    * IS ENTITLED TO ADDITIONAL PAYMENTS OF USD 3.8 MILLION OVER
COURSE OF NEXT THREE YEARS
    * CLOSING OF TRANSACTION, WHICH IS EXPECTED IN Q2 OF 2021

Source text for Eikon:  ID:nGNE2dgTLG 
Further company coverage:  BSLN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))